About: MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Gout Olivier, Vighetto Alain, Deburghgraeve Véronique, Pelletier Jean, Papeix Caroline, Lebrun-Frenay Christine, Labauge Pierre, Brassat David, Toosy Ahmed, Laplaud David-Axel, Outteryck Olivier, Moreau Thibault, Debouverie Marc, Clavelou Pierre, Heinzlef Olivier, De Sèze Jérôme, Defer Gilles, Sedel Frédéric, Arndt Carl. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. CNS Drugs, Springer Verlag, 2018, 32 (7), pp.661-672
  • Gout Olivier, Vighetto Alain, Deburghgraeve Véronique, Pelletier Jean, Papeix Caroline, Lebrun-Frenay Christine, Labauge Pierre, Brassat David, Toosy Ahmed, Laplaud David-Axel, Outteryck Olivier, Moreau Thibault, Debouverie Marc, Clavelou Pierre, Heinzlef Olivier, de Sèze Jérôme, Defer Gilles, Sedel Frédéric, Arndt Carl . MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study . CNS Drugs, 2018, 32 (7), pp.661-672
  • Gout Olivier, Vighetto Alain, Deburghgraeve Véronique, Pelletier Jean, Papeix Caroline, Lebrun-Frenay Christine, Labauge Pierre, Brassat David, Toosy Ahmed, Laplaud David-Axel, Outteryck Olivier, Moreau Thibault, Debouverie Marc, Clavelou Pierre, Heinzlef Olivier, de Sèze Jérôme, Defer Gilles, Sedel Frédéric, Arndt Carl. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. CNS Drugs, 2018, 32 (7), pp.661-672. ⟨10.1007/s40263-018-0528-2⟩
Title
  • MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
dc:date
  • 2018
Digital Object Identifier (DOI)
  • 10.1007/s40263-018-0528-2
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software